Inventor · disambiguated record
Bharat B. Aggarwal
Also filed as: AGGARWAL BHARAT · AGGARWAL BHARAT B · AGGARWAL BHARAT BHUSHAN
35 granted patents·10 pending applications·1,248 citations·filing 1984–2021
98Inventor score
Top patents by PatentIndex Score
45 records- 0196US5795967ATumor necrosis factor antagonists and their useGENENTECH INC·Filed 1995·Granted Aug 18, 1998·350 cites·15 claims
- 0296US5672347ATumor necrosis factor antagonists and their useGENENTECH INC·Filed 1995·Granted Sep 30, 1997·280 cites·7 claims
- 0394US6475986B1Uses of THANK, a TNF homologue that activates apoptosisRES DEV FOUNDATION·Filed 2000·Granted Nov 5, 2002·58 cites·2 claims
- 0493US4650674ASynergistic cytotoxic compositionGENENTECH INC·Filed 1984·Granted Mar 17, 1987·105 cites·8 claims
- 0590US9283185B2Liposomal curcumin for treatment of cancerKURZROCK RAZELLE·Filed 2011·Granted Mar 15, 2016·8 cites·8 claims
- 0690US7563462B2Methods for modulating eicosanoid metabolismUNIV TEXAS MD ANDERSON CANCER·Filed 2006·Granted Jul 21, 2009·22 cites·21 claims
- 0790US7241576B2Uses of THANK, a TNF homologue that activates apoptosisRES DEV FOUNDATION·Filed 2002·Granted Jul 10, 2007·30 cites·1 claims
- 0888US5891924ACurcumin (diferuloylmethane) inhibition of NFκB activationRES DEV FOUNDATION·Filed 1996·Granted Apr 6, 1999·83 cites·2 claims
- 0985US10182997B2Liposomal curcumin for treatment of cancerUNIV TEXAS·Filed 2016·Granted Jan 22, 2019·4 cites·2 claims
- 1084US5650316AUses of triplex forming oligonucleotides for the treatment of human diseasesRES DEV FOUNDATION·Filed 1994·Granted Jul 22, 1997·81 cites·4 claims
- 1180US8252345B2Methods for modulating eicosanoid metabolismNEWMARK THOMAS·Filed 2008·Granted Aug 28, 2012·3 cites·7 claims
- 1280US8114446B2Methods for modulating eicosanoid metabolismNEWMARK THOMAS·Filed 2010·Granted Feb 14, 2012·4 cites·18 claims
- 1379US6998383B2Inhibitors of receptor activator of NF-κB and uses thereofRESEARCH DEV CORP·Filed 2002·Granted Feb 14, 2006·17 cites·13 claims
- 1479US5631348AProtein sequence of the plant toxin geloninRES DEV FOUNDATION·Filed 1994·Granted May 20, 1997·37 cites·2 claims
- 1574US7105576B2Synergistic effects of nuclear transcription factor NF-κB inhibitors and anti-neoplastic agentsRES DEV FOUNDATION·Filed 2003·Granted Sep 12, 2006·5 cites·24 claims
- 1674US5824509ARecombinant lymphotoxin cDNA and variantsGENENTECH INC·Filed 1995·Granted Oct 20, 1998·19 cites·20 claims
- 1773US7368430B2Selective inhibitors of nuclear factor-κB activation and uses thereofRES DEV FOUNDATION·Filed 2004·Granted May 6, 2008·4 cites·35 claims
- 1872US7196105B2Treatment of human multiple myeloma by curcuminRES DEV FOUNDATION·Filed 2003·Granted Mar 27, 2007·4 cites·13 claims
- 1971USRE37462EProtein sequence of the plant toxin geloninRES DEV FOUNDATION·Filed 1999·Granted Dec 4, 2001·20 cites·18 claims
- 2070US4920196AHuman lymphotoxinGENENTECH INC·Filed 1987·Granted Apr 24, 1990·22 cites·28 claims
- 2170US2019105287A1Liposomal Curcumin for Treatment of CancerUNIV TEXAS·Filed 2018·Application pending·0 cites
- 2269US7462646B2Osteoclastogenesis inhibitors and uses thereofRES DEV FOUNDATION·Filed 2004·Granted Dec 9, 2008·3 cites·16 claims
- 2369US5658949AInhibition of tumor necrosis factor by retinoic acidRES DEV FOUNDATION·Filed 1994·Granted Aug 19, 1997·18 cites·15 claims
- 2464US5856161ATumor necrosis factor receptor-I-associated protein kinase and methods for its useRES DEV FOUNDATION·Filed 1996·Granted Jan 5, 1999·21 cites·8 claims
- 2564US2009111754A1Selective Inhibitors of Nuclear Factor KappaB Activation and Uses ThereofAGGARWAL BHARAT B·Filed 2008·Application pending·0 cites
- 2663US2006233899A1Treatment of Human Multiple Myeloma by CurcuminAGGARWAL BHARAT·Filed 2006·Application pending·0 cites
- 2763US2006210656A1Synergistic Effects of Nuclear Transcription Factor NF-kB Inhibitors and Anti-Neoplastic AgentsAGGARWAL BHARAT·Filed 2006·Application pending·0 cites
- 2859US5981583AInhibition of nuclear transcription factor NF-κB by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxinRES DEV FOUNDATION·Filed 1997·Granted Nov 9, 1999·15 cites·3 claims
- 2958US2008103213A1Liposomal curcumin for treatment of neurofibromatosisUNIV TEXAS·Filed 2007·Application pending·0 cites
- 3057US2005049299A1Selective inhibitors of stat-3 activation and uses thereofFiled 2004·Application pending·0 cites
- 3155US2018318217A1Liposomal Curcumin for Treatment of DiseasesUNIV TEXAS·Filed 2018·Application pending·0 cites
- 3254US2005181036A1Aerosol delivery of curcuminRES DEV FOUNDATION·Filed 2004·Application pending·0 cites
- 3351US5683688AUnglycosylated recombinant human lymphotoxin polypeptides and compositionsGENENTECH INC·Filed 1992·Granted Nov 4, 1997·7 cites·23 claims
- 3450US5457129AInhibition of nitric oxide production by retinoic acidRES DEV FOUNDATION·Filed 1993·Granted Oct 10, 1995·6 cites·9 claims
- 3548US2004167072A1Inhibitors of receptor activator of NF-kappaB and uses thereofFiled 2004·Application pending·0 cites
- 3647US6605278B1Uses of trank, a novel secretory cytokineRES DEV FOUNDATION·Filed 1999·Granted Aug 12, 2003·4 cites·3 claims
- 3743US6177543B1Recombinant lymphotoxinGENENTECH INC·Filed 1998·Granted Jan 23, 2001·2 cites·9 claims
- 3843US5977058AAntiproliferative protein from Bacillus thuringiensis var. thuringiensisRES DEV FOUNDATION·Filed 1997·Granted Nov 2, 1999·5 cites·5 claims
- 3943US2006019907A1Guggulsterone: an inhibitor of nuclear factor - kappaB and IkappaBalpha kinase activation and uses thereofRES DEV FOUNDATION·Filed 2005·Application pending·0 cites
- 4041US5837817ATumor necrosis factor receptor-II-associated protein kinase and methods for its useRES DEV FOUNDATION·Filed 1996·Granted Nov 17, 1998·9 cites·1 claims
- 4137US6686455B1Tumor necrosis factorGENENTECH INC·Filed 1995·Granted Feb 3, 2004·1 cites·3 claims
- 4233US12211263B2System and method for assessing pixels of satellite images of agriculture land parcel using AISATSURE ANALYTICS INDIA PRIVATE LTD·Filed 2021·Granted Jan 28, 2025·0 cites·15 claims
- 4331US5241051AOncoinhibinRES DEV FOUNDATION·Filed 1992·Granted Aug 31, 1993·1 cites·7 claims
- 4430US5993798AOncoinhibin and methods of pharmaceutical useRES DEV FOUNDATION·Filed 1994·Granted Nov 30, 1999·0 cites·6 claims
- 4525US5824636AAntiproliferative protein from Bacillus thuringiensis var. thuringiensisRESEARCH DEV CORP·Filed 1996·Granted Oct 20, 1998·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →